FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biochemistry, particularly to a medicinal product for treating or preventing cancer, containing an antibody as an active ingredient, which possesses an immune responsiveness to CAPRIN-1 protein. There are also disclosed an antibody, which possesses an immune responsiveness to CAPRIN-1 protein, a pharmaceutical combination containing the above medicinal product for treating or preventing cancer. Disclosed is a method for treating or preventing cancer with the use of the above medicinal product and the pharmaceutical combination.
EFFECT: invention possesses an ability to bind to CAPRIN-1 specifically that enables treating the diseases associated with CAPRIN-1 polypeptide expression effectively.
8 cl, 3 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2607366C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2598258C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2597971C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | 2013 |
|
RU2633505C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | 2013 |
|
RU2639522C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | 2013 |
|
RU2632645C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT OR PREVENTION | 2013 |
|
RU2631804C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2603742C2 |
DRUGS FOR CANCER TREATMENT AND/OR PREVENTION | 2011 |
|
RU2624029C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING AND PREVENTING MALIGNANT GROWTHS | 2009 |
|
RU2498819C2 |
Authors
Dates
2015-11-10—Published
2011-02-04—Filed